Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Multiple Sclerosis

  Free Subscription


29.03.2021

1 Acta Neurol Scand
1 AJNR Am J Neuroradiol
1 Ann Neurol
1 BMC Neurol
1 Brain
1 Clin Exp Immunol
1 Eur Neurol
1 J Immunol
1 J Neuroimmunol
4 Mult Scler
1 Nervenarzt
2 Neurologia
1 PLoS One
1 Rev Neurol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Neurol Scand

  1. KAVALIUNAS A, Danylaite Karrenbauer V, Hillert J
    Socioeconomic consequences of multiple sclerosis-A systematic literature review.
    Acta Neurol Scand. 2021 Mar 22. doi: 10.1111/ane.13411.
    PubMed         Abstract available


    AJNR Am J Neuroradiol

  2. PRAVATA E, Roccatagliata L, Sormani MP, Carmisciano L, et al
    Dedicated 3D-T2-STIR-ZOOMit Imaging Improves Demyelinating Lesion Detection in the Anterior Visual Pathways of Patients with Multiple Sclerosis.
    AJNR Am J Neuroradiol. 2021 Mar 25. pii: ajnr.A7082. doi: 10.3174/ajnr.A7082.
    PubMed         Abstract available


    Ann Neurol

  3. NOURBAKHSH B, Cordano C, Asteggiano C, Ruprecht K, et al
    Multiple Sclerosis Is Rare in Epstein-Barr Virus-Seronegative Children with Central Nervous System Inflammatory Demyelination.
    Ann Neurol. 2021 Mar 11. doi: 10.1002/ana.26062.
    PubMed         Abstract available


    BMC Neurol

  4. NETER E, Glass-Marmor L, Wolkowitz A, Lavi I, et al
    Beliefs about medication as predictors of medication adherence in a prospective cohort study among persons with multiple sclerosis.
    BMC Neurol. 2021;21:136.
    PubMed         Abstract available


    Brain

  5. ONTANEDA D, Raza PC, Mahajan KR, Arnold DL, et al
    Deep grey matter injury in multiple sclerosis: A NAIMS consensus statement.
    Brain. 2021 Mar 23. pii: 6184142. doi: 10.1093.
    PubMed         Abstract available


    Clin Exp Immunol

  6. HAQUE R, Kim Y, Park K, Jang H, et al
    Altered distributions in circulating follicular helper and follicular regulatory T cells accountable for imbalanced cytokine production in multiple sclerosis.
    Clin Exp Immunol. 2021 Mar 24. doi: 10.1111/cei.13596.
    PubMed         Abstract available


    Eur Neurol

  7. ALHOMOUD MA, Khan AS, Alhomoud I
    The Potential Preventive Effect of Pregnancy and Breastfeeding on Multiple Sclerosis.
    Eur Neurol. 2021 Mar 19:1-14. doi: 10.1159/000514432.
    PubMed         Abstract available


    J Immunol

  8. RIJVERS L, Melief MJ, van Langelaar J, van der Vuurst de Vries RM, et al
    The Role of Autoimmunity-Related Gene CLEC16A in the B Cell Receptor-Mediated HLA Class II Pathway.
    J Immunol. 2020 Jul 8. pii: jimmunol.1901409. doi: 10.4049/jimmunol.1901409.
    PubMed         Abstract available


    J Neuroimmunol

  9. LAZAREVIC M, Djedovic N, Stanisavljevic S, Dimitrijevic M, et al
    Complete Freund's adjuvant-free experimental autoimmune encephalomyelitis in Dark Agouti rats is a valuable tool for multiple sclerosis studies.
    J Neuroimmunol. 2021;354:577547.
    PubMed         Abstract available


    Mult Scler

  10. HARROUD A, Mitchell RE, Richardson TG, Morris JA, et al
    Childhood obesity and multiple sclerosis: A Mendelian randomization study.
    Mult Scler. 2021 Mar 22:13524585211001781. doi: 10.1177/13524585211001781.
    PubMed         Abstract available

  11. LEE LE, Vavasour IM, Dvorak A, Liu H, et al
    Cervical cord myelin abnormality is associated with clinical disability in multiple sclerosis.
    Mult Scler. 2021 Mar 22:13524585211001780. doi: 10.1177/13524585211001780.
    PubMed         Abstract available

  12. PORTACCIO E, Fonderico M, Hemmer B, Derfuss T, et al
    Impact of COVID-19 on multiple sclerosis care and management: Results from the European Committee for Treatment and Research in Multiple Sclerosis survey.
    Mult Scler. 2021 Mar 25:13524585211005339. doi: 10.1177/13524585211005339.
    PubMed         Abstract available

  13. CREE BA, Cohen JA, Reder AT, Tomic D, et al
    Disability improvement as a clinically relevant outcome in clinical trials of relapsing forms of multiple sclerosis.
    Mult Scler. 2021 Mar 26:13524585211000280. doi: 10.1177/13524585211000280.
    PubMed         Abstract available


    Nervenarzt

  14. EDWIN THANARAJAH S, Wendy H, Reif A, Reif-Leonhard C, et al
    [Acute psychotic episode as a primary clinical manifestation of multiple sclerosis-a case report].
    Nervenarzt. 2021 Mar 24. pii: 10.1007/s00115-021-01107.
    PubMed        


    Neurologia

  15. LOPEZ-GOMEZ J, Sacristan-Enciso B, Caro-Miro MA
    Clinically isolated syndrome: diagnosis and risk of developing clinically definite multiple sclerosis.
    Neurologia. 2021 Mar 20. pii: S0213-4853(21)00028.
    PubMed         Abstract available

  16. LLUFRIU S, Aguera E, Costa-Frossard L, Galan V, et al
    Recommendations for the coordination of Neurology and Neuroradiology Departments in the management of patients with multiple sclerosis.
    Neurologia. 2021 Mar 17. pii: S0213-4853(21)00029.
    PubMed         Abstract available


    PLoS One

  17. GOODIN DS, Khankhanian P, Gourraud PA, Vince N, et al
    The nature of genetic and environmental susceptibility to multiple sclerosis.
    PLoS One. 2021;16:e0246157.
    PubMed         Abstract available


    Rev Neurol

  18. COSTA FROSSARD-FRANCA L, Garcia-Dominguez JM, Moreno-Torres I, Fortun J, et al
    [Vaccination against SARS-CoV-2 in patients with multiple sclerosis].
    Rev Neurol. 2021;72:250-260.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: